Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease

Hayoung Choi, Byung Woo Jhun, Su Young Kim, Dae Hun Kim, Hyun Lee, Kyeongman Jeon, O. Jung Kwon, Hee Jae Huh, Chang Seok Ki, Nam Yong Lee, Sung Jae Shin, Charles L. Daley, Won Jung Koh

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Mycobacterium abscessus lung disease is difficult to treat due to inducible resistance to macrolides. However, 15%–20% of isolates are macrolide susceptible. In 14 patients with macrolide-susceptible M. abscessus lung disease, all isolates had nonfunctional erm(41) gene, and sputum culture conversion rate was achieved in 93% (13/14) following antibiotic therapy.

Original languageEnglish
Pages (from-to)293-295
Number of pages3
JournalDiagnostic Microbiology and Infectious Disease
Volume90
Issue number4
DOIs
Publication statusPublished - 2018 Apr

Bibliographical note

Funding Information:
This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning ( NRF-2015R1A2A1A01003959 ) and the Ministry of Education ( NRF-2016R1A6A3A11930364 ).

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease'. Together they form a unique fingerprint.

Cite this